News | Search | Subscribe | My Account | About Us | Contact Us | Repertoire Home
June 30, 2016

Manufacturer News

  • FDA grants Breakthrough Therapy Designation to J&J’s Ibrutinib (IMBRUVICA) for the development of a treatment for chronic graft-versus-host disease
  • Provider Services News

  • Definitive Healthcare acquires Billian’s HealthDATA
  • Merck, Premier Inc agree to collaborate on population health initiatives, starting with reducing fracture rates for at-risk osteoporosis patients
  • Hospital and IDN News

  • Siemens Healthineers announces first install of Multitom Rax Twin Robotic X-ray system
  • HHS selects 196 physician groups for cancer care initiative
  • Baptist Health to acquire Floyd Memorial Hospital for $300M
  • GPO News

  • AllSpire Health Partners forms new GPO
  • Intalere signs new agreement with Plus Pharma
  • Stock Watch

  • Health Stocks
  • Manufacturer News
    FDA grants Breakthrough Therapy Designation to J&J’s Ibrutinib (IMBRUVICA) for the development of a treatment for chronic graft-versus-host disease

    The FDA granted to Janssen Research & Development LLC, a part of Johnson & Johnson (New Brunswick, NJ), a fourth Breakthrough Therapy Designation (BTD) for ibrutinib (IMBRUVICA) as monotherapy for the treatment of patients with chronic graft-versus-host-disease (cGVHD) after failure of one or more lines of systemic therapy. The FDA also granted the therapy Orphan Drug Designation (ODD) for cGVHD. This is the first time ibrutinib has been granted BTD or ODD for an indication beyond hematologic malignancies.

    -back to top-
    Provider Services News
    Definitive Healthcare acquires Billian’s HealthDATA

    Definitive Healthcare (Natick, MA) has acquired Billian’s HealthDATA (Atlanta, GA), a provider of data and analytics on U.S. healthcare organizations. The acquisition comes just eight months after Definitive’s acquisition of U.S. Lifeline (USL) and its database of healthcare providers, The MAX, from MDSI (Lawrenceville, GA). Through the acquisition of USL/The MAX, Definitive added significant depth to its supply chain data, particularly with IDN and GPO relationships, addressing an important market need. The acquisition of Billian's will expand Definitive’s extensive data on healthcare providers and facilities. "This acquisition is just another step in our effort to become the number one provider of the high quality, integrated data on IDNs, Hospitals, Physicians and other Providers,” states Jason Krantz, CEO of Definitive Healthcare. "Billians HealthData brings a marquee customer list and data assets that will help us achieve our goals even more quickly." Billian’s HealthDATA provides intelligence on hospitals and other healthcare facilities, physician groups, ACOs, and GPOs. Included in the data are well over a million key decision makers and a million physician contacts. The deal closed June 22, 2016. Terms of the deal were not disclosed.

    -back to top-
    Merck, Premier Inc agree to collaborate on population health initiatives, starting with reducing fracture rates for at-risk osteoporosis patients

    Merck (Kenilworth, NJ) and Premier Inc (Charlotte, NC) agreed to collaborate on the co-development of solutions to help improve population health. The companies will initially focus on reducing fracture rates for at-risk osteoporosis patients. The collaboration agreement combines expertise and assets from Merck, Premier’s performance improvement framework and analytics, Premier’s alliance of health systems, and other healthcare leaders to jointly develop and test effective solutions to help improve patient care and wellness, and lower healthcare spending. Merck and Premier will work with the National Osteoporosis Foundation to co-develop and test performance improvement solutions, including educational initiatives that are designed to help improve the quality of care for diagnosed untreated patients at risk of osteoporotic fracture. The organizations will work to identify a core set of metrics for osteoporosis care and fracture prevention that align with measures endorsed by the National Quality Forum, as well as other quality measures such as Physician Quality Reporting System measures. The collaboration will integrate Premier’s CECity quality improvement analytics platform, the measure set, as well as interventions for improvement such as virtual collaboration community tools and performance reports, into a cloud-based application to be automated and tested within volunteer Premier member health systems. Financial terms of the agreements were not disclosed.

    -back to top-
    Hospital and IDN News
    Siemens Healthineers announces first install of Multitom Rax Twin Robotic X-ray system

    Siemens Healthineers (Malvern, PA) announced that University of Utah Health Care (Salt Lake City, UT) is the first facility in the U.S. to install the company’s Multitom Rax Twin Robotic X-ray system, a universal diagnostic imaging system that enables a wide range of examinations in multiple clinical areas in one room using a single X-ray system. With the Multitom Rax, users can perform exams pertaining to everything from emergency medicine and interventional to pain management and orthopedics, and from conventional 2D radiography to fluoroscopy exams and angiography applications. The world’s first Twin Robotic X-ray system, the Multitom Rax features a unique design that allows the acquisition of 3D natural weight-bearing images. The open design of the Multitom Rax Twin Robotic X-ray system features a height-adjustable patient table and two independent, ceiling-mounted robotic arms for the X-ray tube head and the flat-panel detector for almost unlimited positioning freedom anywhere in the room. Both robotic arms can be moved into position automatically or manually with servo motor support to make fine adjustments. While one robotic arm moves the X-ray tube, the other arm carries the 17” x 17” flat panel detector, which can acquire static, dynamic, and Real 3D sequences.

    -back to top-
    HHS selects 196 physician groups for cancer care initiative

    The U.S. Department of Health and Human Services (HHS) selected 196 physician group practices and 17 health insurance companies to participate in a care delivery model that supports and encourages higher quality and more coordinated cancer care. The Medicare arm of the Oncology Care Model includes more than 3,200 oncologists and will cover approximately 155,000 Medicare beneficiaries nationwide. The Oncology Care Model begins July 1, 2016 and runs through June 30, 2021. The Oncology Care Model encourages practices to improve care and lower costs through episodic and performance-based payments that reward high-quality patient care. The Oncology Care Model is one of the first CMS physician-led specialty care models and builds on lessons learned from other innovative programs and private-sector models. As part of this model, physician practices may receive performance-based payments for episodes of care surrounding chemotherapy administration to Medicare patients with cancer, as well as a monthly care management payment for each beneficiary. The two-sided risk track of this model will be an Advanced Alternative Payment Model under the newly proposed Quality Payment Program, implementing provisions from the Medicare Access and CHIP Reauthorization Act of 2015. To read more about the new model, visit

    -back to top-
    Baptist Health to acquire Floyd Memorial Hospital for $300M

    Baptist Health (Louisville, KY) signed a binding asset purchase agreement to acquire Floyd Memorial Hospital and Health Services. The deal has received approval from government officials and the boards of both hospitals. Signing of the agreement is the second step toward the hospital being acquired by Baptist Health. After closing, the hospital will be known as Baptist Health Floyd. The sale price which, totals over $300 million, includes capital investments by Baptist Health in Baptist Health Floyd of $140 million over the next seven years to expand services, invest in improved technologies and transition to Epic’s EHR. Because the hospital was county-owned, Floyd County will receive about $75 million at closing (after paying transaction costs). An additional $61 million will be paid over the next 10 years, some designated for ongoing healthcare-related needs and activities. Baptist said it will hire all non-contracted Floyd Memorial employees at their existing pay rates if employees pass required pre-employment screening .The closing of the transaction is expected to occur September 30, 2016.

    -back to top-
    GPO News
    AllSpire Health Partners forms new GPO

    AllSpire Health Partners (CS) formed a group purchasing organization (GPO) with six of its health systems. The new entity, AllSpire Health GPO LLC, will be governed by a board of directors consisting of one senior executive representative from each member organization. Its operating committee is composed of supply chain leaders from each organization. The GPO will be headquartered in the Lehigh Valley region of Pennsylvania and become operational in Q3 2016. AllSpire Health GPO has signed an exclusive agreement with a national GPO provider, HealthTrust (Brentwood, TN). Each participant in the AllSpire Health GPO will become a member of HealthTrust, with full access to its extensive contract portfolio. Health systems that are participating in the AllSpire Health GPO include:
    - Atlantic Health System (Morristown, NJ)
    - Hackensack University Health Network (Hackensack, NJ)
    - Lehigh Valley Health Network (Allentown, PA)
    - Meridian Health (Neptune, NJ)
    - Reading Health System (Reading, PA)
    - WellSpan Health (York, PA)

    -back to top-
    Intalere signs new agreement with Plus Pharma

    Intalere (St. Louis, MO) formed a new agreement with Plus Pharma Inc (Vista, CA) for over-the-counter (OTC) pharmaceuticals and vitamins. Through the agreement, Intalere members will receive negotiated pricing on Plus Pharma’s generic OTC pharmaceuticals and vitamin products, which are available in various packaging configurations: retail/consumer sizes as well as unit-dose and bulk-dispensing sizes. The contract is currently effective through September 30, 2017.

    -back to top-
    Stock Watch
    Health Stocks

    Quotes last updated at 6/29/2016 4:22:19 PM EST

    Company Price Change Trends
    S&P 500 Index 2070.77 +34.68 Analyze
    NASDAQ Composite 4779.25 +87.38 Analyze
    ABBVIE INC 61.80 +1.81 Analyze
    AMERISOURCEBERGN 77.26 +1.94 Analyze
    ABBOTT LABS 38.57 +1.01 Analyze
    ALERE INC 41.45 +0.20 Analyze
    BAXTER INTL INC 44.805 +1.425 Analyze
    CR BARD INC 232.32 +4.70 Analyze
    BECTON DICKINSON 168.13 +4.05 Analyze
    BRISTOL MYERS SQ 73.00 +1.37 Analyze
    BOSTON SCIENTIFIC 23.035 +0.685 Analyze
    BOVIE MEDICAL CORP 1.70 -0.02 Analyze
    CARDINAL HEALTH 77.27 +2.29 Analyze
    CERNER CORP 57.48 +2.40 Analyze
    CLOROX 135.21 -1.45 Analyze
    CONMED CORP 45.91 +1.41 Analyze
    CEPHEID 29.55 +0.71 Analyze
    CRYOLIFE 11.72 +0.09 Analyze
    DANAHER 100.12 +2.00 Analyze
    DYNACQ HEALTHCARE 0.06 +0.00 Analyze
    EXPRESS SCRIPTS 75.70 +1.69 Analyze
    GENERAL ELECTRIC COMPANY 30.55 +0.61 Analyze
    HCA 77.04 +1.11 Analyze
    HMS HOLDINGS 17.35 +0.28 Analyze
    HOLOGIC INC 34.06 +0.71 Analyze
    HILL-ROM HOLDINGS INC 49.20 +1.14 Analyze
    HENRY SCHEIN 175.52 +4.25 Analyze
    HEALTHSTREAM INC 26.51 +1.34 Analyze
    ICU MEDICAL 111.13 +2.88 Analyze
    JOHNSON & JOHNSON 119.33 +1.10 Analyze
    MASIMO CORP 51.56 +0.95 Analyze
    MCKESSON CORP 183.33 +6.75 Analyze
    MEDASSETS 31.35 +0.00 Analyze
    MEDTRONIC INC 85.45 +1.31 Analyze
    MIMEDX GROUP INC 7.88 +0.19 Analyze
    3M COMPANY 171.47 +1.88 Analyze
    MERIT MEDICAL SYSTEMS 19.48 +0.74 Analyze
    MICROSOFT 50.54 +1.10 Analyze
    MYLAN LABS 43.22 +0.40 Analyze
    OMNICELL 34.28 +0.61 Analyze
    OWENS & MINOR 36.72 +0.30 Analyze
    PHILIPS 24.40 +0.68 Analyze
    PREMIER INC 32.37 +0.84 Analyze
    QUIDEL CORP 17.64 +0.14 Analyze
    SUPERIOR UNIFORM GROUP 18.55 -0.25 Analyze
    SMITH & NEPHEW 33.60 +0.97 Analyze
    STERIS CORP 67.37 +2.35 Analyze
    STANLEY BLACK & DECKER INC 108.08 +1.86 Analyze
    STRYKER CORP 118.80 +2.84 Analyze
    TELEFLEX MEDICAL 173.72 +2.32 Analyze
    THERMO FISHER SCI 145.15 +2.00 Analyze
    ZIMMER HOLDINGS 113.56 +0.00 Analyze
    -back to top-

    Copyright © , MDSI. All Rights Reserved.
    Privacy Policy